Bausch + Lomb Corporation (BLCO)
NYSE·Healthcare·Medical - Instruments & Supplies
$15.74
-0.88%
Mkt Cap $5.69B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 18, 2026 | $1.39B | $1.41B | +1.42% | $0.35 | $0.32 | -8.57% | — | — |
| Q4 2025 Oct 29, 2025 | $1.38B | $1.28B | -7.40% | $0.16 | $0.18 | +12.50% | — | — |
| Q3 2025 Jul 30, 2025 | $1.27B | $1.28B | +0.31% | $0.06 | $0.07 | +16.67% | — | — |
| Q2 2025 Apr 30, 2025 | $1.25B | $1.13B | -9.58% | $0.03 | -$0.07 | -333.33% | — | — |
| Q1 2025 Feb 19, 2025 | $1.15B | $1.28B | +11.23% | $0.24 | $0.25 | +4.17% | — | — |
| Q4 2024 Oct 30, 2024 | $1.25B | $1.20B | -4.69% | $0.16 | $0.17 | +6.25% | — | — |
| Q3 2024 Jul 31, 2024 | $1.61B | $1.22B | -24.28% | $0.13 | $0.13 | +0.00% | — | — |
| Q2 2024 May 1, 2024 | $1.62B | $1.10B | -32.07% | $0.09 | $0.07 | -22.22% | — | — |
| Q1 2024 Feb 21, 2024 | $1.50B | $1.17B | -21.67% | $0.17 | $0.24 | +41.18% | — | — |
| Q4 2023 Nov 1, 2023 | $1.36B | $1.01B | -26.03% | $0.18 | $0.22 | +22.22% | — | — |
| Q3 2023 Aug 2, 2023 | $962.03M | $1.03B | +7.59% | $0.16 | $0.18 | +12.50% | — | — |
| Q2 2023 May 3, 2023 | $1.28B | $931.00M | -27.20% | $0.14 | $0.10 | -28.57% | — | — |
| Q1 2023 Feb 22, 2023 | $966.92M | $996.00M | +3.01% | $0.22 | $0.23 | +4.55% | — | — |
| Q4 2022 Nov 2, 2022 | $949.72M | $942.00M | -0.81% | $0.23 | $0.31 | +34.78% | — | — |
| Q3 2022 Aug 4, 2022 | $908.52M | $941.00M | +3.58% | $0.20 | $0.29 | +45.00% | — | — |
| Q2 2022 May 6, 2022 | $889.00M | $889.00M | +0.00% | $0.23 | $0.06 | -75.58% | — | — |
| Q4 2021 Dec 31, 2021 | — | $1.00B | — | — | $0.15 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $949.00M | — | — | $0.17 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $934.00M | — | — | $0.13 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $881.00M | — | — | $0.08 | — | — | — |